TY - JOUR
T1 - Surgical management of sarcomas
AU - Cheng, Edward Y.
PY - 2005/6/1
Y1 - 2005/6/1
N2 - Nearly all bone and soft tissue sarcomas will require surgical management. Early consultation with a surgeon who is experienced in sarcomas, before a biopsy is performed, will avoid potential errors that may complicate subsequent surgery. Advances in imaging, neoadjuvant therapies, and reconstructive techniques have improved the ability to adequately resect most bone and soft tissue sarcomas. The use of oncologic and functional outcomes assessment tools facilitates the development of improved treatments for sarcoma patients. Results from major centers reveal that most patients with a nonmetastatic bone or soft tissue sarcoma will survive 5 years after surgery combined with either chemotherapy or radiation.
AB - Nearly all bone and soft tissue sarcomas will require surgical management. Early consultation with a surgeon who is experienced in sarcomas, before a biopsy is performed, will avoid potential errors that may complicate subsequent surgery. Advances in imaging, neoadjuvant therapies, and reconstructive techniques have improved the ability to adequately resect most bone and soft tissue sarcomas. The use of oncologic and functional outcomes assessment tools facilitates the development of improved treatments for sarcoma patients. Results from major centers reveal that most patients with a nonmetastatic bone or soft tissue sarcoma will survive 5 years after surgery combined with either chemotherapy or radiation.
UR - http://www.scopus.com/inward/record.url?scp=20444368060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20444368060&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2005.03.009
DO - 10.1016/j.hoc.2005.03.009
M3 - Review article
C2 - 15939191
AN - SCOPUS:20444368060
SN - 0889-8588
VL - 19
SP - 451
EP - 470
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 3
ER -
